Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model
- Resource Type
- Article
- Source
- In
European Journal of Pharmaceutics and Biopharmaceutics June 2024 199 - Subject
- Language
- ISSN
- 0939-6411